Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease
Clinical trial NCT00809302 · TERMINATED
Trial details
- NCT number
- NCT00809302
- Sponsor
- Neurogen Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2009-08-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.